References
21 citations / PubMed, PMC, and journal links / DOIs where available
Citation grid: 21 references color-coded by evidence category. Green = mechanistically established preclinical findings. Blue = human pilot studies. Amber = preclinical-only or open questions. Red = regulatory context.
Citation Index
Citation Index
All 21 citations used across this site are listed below with full bibliographic data, DOI, and PubMed/PMC URL where available. All outbound links point to primary sources: PubMed, PubMed Central, journal publisher pages, ClinicalTrials.gov, and ResearchGate.
-
01
Staresinic M, Sebecic B, Patrlj L, et al. Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth. Journal of Orthopaedic Research. 2003;21(6):976-983. DOI 10.1016/S0736-0266(03)00110-4 ↗
-
02
Chang CH, Tsai WC, Hsu YH, Pang JHS. Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts. Molecules. 2014;19(11):19066-19077. PMID: 25415472. PMC6271067 ↗
-
03
Cerovecki T, Bojanic I, Brcic L, et al. Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat. Journal of Orthopaedic Research. 2010;28(9):1155-1161. PMID: 20225319. DOI 10.1002/jor.21107 ↗
-
04
Seiwerth S, Rucman R, Turkovic B, et al. Stable Gastric Pentadecapeptide BPC 157 and Wound Healing. Frontiers in Pharmacology. 2021;12:627533. PMID: 34267654. PMC8275860 ↗
-
05
Novinscak T, Brcic L, Staresinic M, et al. Gastric pentadecapeptide BPC 157 as an effective therapy for muscle crush injury in the rat. Surgery Today. 2008;38(8):716-725. PMID: 18668315. PubMed 18668315 ↗
-
06
Sebecic B, Nikolic V, Sikiric P, et al. Osteogenic effect of a gastric pentadecapeptide, BPC-157, on the healing of segmental bone defect in rabbits: a comparison with bone marrow and autologous cortical bone implantation. Bone. 1999;24(3):195-202. PMID: 10071911. PubMed 10071911 ↗
-
07
Brcic L, Brcic I, Staresinic M, et al. Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing. Journal of Physiology and Pharmacology. 2009;60 Suppl 7:191-196. PMID: 20388964. PubMed 20388964 ↗
-
08
Sikiric P, Seiwerth S, Rucman R, et al. Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. World Journal of Gastroenterology. 2022;28(1):23-45. PMID: 35125818. PMC8793015 ↗
-
09
Sikiric P, Boban Blagaic A, Strbe S, et al. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity. Pharmaceuticals (Basel). 2024;17(4):461. PMID: 38675421. PubMed 38675421 ↗
-
10
Sikiric P, Boban Blagaic A, Strbe S, et al. The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity [serotonin findings]. Pharmaceuticals (Basel). 2024;17(4):461. PMID: 38675421. PubMed 38675421 ↗
-
11
He L, Feng D, Guo H, et al. Pharmacokinetics, distribution, metabolism, and excretion of body-protective compound 157, a potential drug for treating various wounds, in rats and dogs. Frontiers in Pharmacology. 2022;13:1026182. PMID: 36588717. PMC9794587 ↗
-
12
Tepes M, Vrdoljak B, Petrovic I, et al. Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in Rats. Pharmaceuticals (Basel). 2023;16(11):1554. PMID: 38004420. PMC10675657 ↗
-
13
Sikiric P, Seiwerth S, Skrtic A, et al. Stable Gastric Pentadecapeptide BPC 157 as a Therapy and Safety Key: A Special Beneficial Pleiotropic Effect Controlling and Modulating Angiogenesis and the NO-System. Pharmaceuticals (Basel). 2025;18(6):928. PMC12195719 ↗
-
14
Lee E, Burgess K. Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study. Alternative Therapies in Health and Medicine. 2025. PMID: 40131143. PubMed 40131143 ↗
-
15
Lee E, Walker C, Ayadi B. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot Study. Alternative Therapies in Health and Medicine. 2024. ResearchGate ↗
-
16
Lee E, Padgett B. Intra-Articular Injection of BPC-157 for Multiple Types of Knee Pain. Alternative Therapies in Health and Medicine. 2021. PMID: 33609460. PubMed 33609460 ↗
-
17
Vasireddi N, Hahamyan H, Salata MJ, et al. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review. HSS Journal. 2025. DOI 10.1177/15563316251355551 ↗
-
18
Matek D, Matek I, Staresinic E, et al. Stable Gastric Pentadecapeptide BPC 157 as Therapy After Surgical Detachment of the Quadriceps Muscle from Its Attachments for Muscle-to-Bone Reattachment in Rats. Pharmaceutics. 2025;17(1):119. PMID: 39861766. PMC11768438 ↗
-
19
NCT02637284. Phase I Study of BPC-157 Peptide. ClinicalTrials.gov registration, 2015 — trial not completed. ClinicalTrials.gov ↗
-
20
Jozwiak M, Bauer M, Kamysz W, Kleczkowska P. Multifunctionality and Possible Medical Application of the BPC 157 Peptide — Literature and Patent Review. Pharmaceuticals (Basel). 2025;18(2):185. PMC11859134 ↗
-
21
Yuan C, Demers A, Silva-Ortiz V, et al. From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management. International Journal of Molecular Sciences. 2026;27(6):2876. PMID: 41898733. PubMed 41898733 ↗